The Global Health Observatory
Explore a world of health data
Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents. Five hepatitis viruses - hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus ( HCV), hepatitis D virus (HDV) and hepatitis E virus (HEV) can infect humans and cause hepatitis.
HBV and HCV infection can become chronic and cause cirrhosis and liver cancer.
Data from 187 countries shows that viral hepatitis is a major public health challenge of this decade. An estimated 1.3 million people died from chronic viral hepatitis B and C in 2022, i.e., 3500 deaths per day. An estimated 254 million people are living with hepatitis B and 50 million people are living with hepatitis C worldwide, and 6000 people are newly infected with viral hepatitis each day. Many people remain undiagnosed in many countries, and even when hepatitis is diagnosed, the number of people receiving treatment remains incredibly low.
High-impact interventions are available, such as an effective cure for hepatitis C and vaccines for hepatitis B, but access to these interventions must be urgently expanded to save lives and prevent a future generation of new infections, cancers and deaths.
Key figures
Hepatitis B highlights 2022
Hepatitis C highlights 2022
Related indicators
-
Hepatitis - number of chronic hepatitis B-infected persons treated
-
Hepatitis - number of persons initiated hepatitis C treatment, latest year and cumulative over a period of years
-
Hepatitis - chronic hepatitis treatment rate as percentage of diagnosed
-
Hepatitis - chronic hepatitis treatment rate as percentage of total infected
Related content
Publications
Consolidated guidelines on person-centred viral hepatitis strategic information: using data to support...
This publication summarizes the approach proposed by WHO to collect, analyse, report, disseminate and use strategic information on viral hepatitis at the...
Guidance for country validation of viral hepatitis elimination and path to elimination
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully...
Health topic
Fact sheet
Related team
Contact us
Please send us your comment or question by e-mail.